Senseonics Holdings (SENS) Announces FDA Approval of World's First Long-Term Implantable Continuous Glucose Monitoring System
Tweet Send to a Friend
Senseonics Holdings, Inc. (NYSE: SENS) today announced the U.S. Food and Drug Administration has approved its Premarket Approval (PMA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
